After doing public relations for two of the most powerful names in fashion, Remi Barbier decided to open his own boutique PR firm, RBPR, and hasn’t looked back. The French-born flack tells us how he’s ...

Alzheimer's drug developer Cassava Sciences (NASDAQ:SAVA) has struck a consulting agreement with its former chief executive officer, Remi Barbier, nearly two months after his resignation. The ...

Cassava Sciences (NASDAQ:SAVA) on Wednesday announced changes in executive leadership, with Richard Barry taking over as the company’s principal executive officer and executive chairman of the board.

Excuse Remi Barbier if he doesn't get the joke. Excuse Remi Barbier if he doesn't get the joke. The Food and Drug Administration said Monday that it approved a reformulation of Purdue Pharma's pain ...

Cassava Sciences, a small Austin, Texas-based drugmaker that has no products on the market after 20 years, became the top biotech performer in 2021 after its stock rose 911 percent following the June ...

Shares of Cassava Sciences Inc. dropped more than 12% in the extended session Thursday after announcing a settlement with U.S. securities regulators, who had charged the pharma company and two former ...

Cassava Sciences Inc., a drugmaker with no products on the market after 20 years, is the top biotech performer in 2021 with an increase of 911%. Behind this meteoric rise is a combination of optimism ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Few companies have experienced stock market peaks and ...